Skip to content
PubMed This is a summary of 7 peer-reviewed journal articles Updated
Surgical Oncology · Esophageal Cancer

What Is an R0 Resection in Esophageal Cancer Surgery?

At a Glance

An R0 resection means no visible tumor remains after esophageal cancer surgery and no cancer is found at the examined margins. It is the best surgical result, but it does not guarantee that cancer has not spread elsewhere; your outlook also depends on stage, lymph nodes, and treatment response.

When your surgeon says their goal is an R0 resection, they mean removing the esophageal tumor so completely that no detectable cancer remains at the surgical site [1]. In surgical and pathology terms, “R” stands for residual tumor (cancer left behind after surgery).

An R0 resection means the surgeon removed all visible tumor during the operation, and the pathologist found no cancer cells at the cut edges of the removed tissue [1]. An R1 resection means the surgeon removed all visible tumor, but the pathologist found microscopic cancer cells at or very close to the tissue edges [2]. An R2 resection means that visible, gross tumor was left behind in the chest, often because it was attached to vital organs or blood vessels and could not be safely removed [1].

The “R” Classifications Explained

Your final “R status” is determined by combining what the surgeon saw during the operation with what the pathologist found under the microscope. The findings are categorized into three statuses:

Classification Meaning How it is Determined
R0 (Complete) No residual cancer at the surgical site. Surgeon sees no tumor left; pathologist confirms clear margins [1].
R1 (Microscopic) Microscopic cancer remains. Surgeon sees no tumor left; pathologist finds cancer cells at the microscopic edges [2].
R2 (Macroscopic) Visible cancer remains. Surgeon sees that some tumor had to be left behind during the operation [1].

It is important to understand that an R0 resection means there is no cancer at the surgical site. It does not guarantee that no cancer cells exist elsewhere in the body [3].

Surgical Margins: Where the Pathologist Looks

To help determine if you have an R1 or R0 status, the pathologist examines the edges of the removed tissue—known as surgical margins—under a microscope. They check two main areas:

  • Longitudinal margins: The top (proximal) and bottom (distal) ends of the removed esophagus [4].
  • Circumferential (radial) margin: The outer tissue wrapping around the sides of the esophagus. This is critical because the esophagus is surrounded by limited soft tissue and sits near the heart and major blood vessels [5][4].

Having a positive circumferential margin (an R1 resection) is associated with a higher risk of the cancer returning in the chest and shorter overall survival [6]. However, the definition of a “positive” margin can vary. Some pathology laboratories define it as cancer cells directly touching the inked cut edge, while others classify a margin as positive if cancer cells are within 1 millimeter of the edge [6]. When reading your report, look for the actual distance measured in millimeters. A “close” margin is not always classified as a positive margin, depending on the standards your hospital uses.

Life After Surgery: Next Steps Based on R Status

An R0 resection is the ultimate surgical goal because it is essential for a realistic chance at curing esophageal cancer [1]. If cancer cells are left behind (R1 or R2), those remaining cells can continue to grow.

When an R1 resection occurs, it usually prompts your multidisciplinary care team (tumor board) to review your case and discuss further treatment options. Depending on your overall health, the exact margin distance, and whether you already received treatments like chemotherapy or radiation before surgery, your team may recommend adjuvant therapy (treatments given after surgery). In some studies, patients who received adjuvant therapy after an R1 resection experienced better survival than those who did not, but recommendations are highly individualized [7].

An R2 (macroscopic) resection is generally associated with a poorer prognosis, as gross tumor remains [1]. While this can be distressing to hear, it often shifts the treatment goal from surgical cure toward disease control. Your specialist team will determine whether further treatments like radiation, chemotherapy, or symptom management are the best next steps.

The Big Picture: Beyond the R Status

While achieving an R0 resection is the best possible surgical outcome, it is only one piece of the puzzle. Sometimes, microscopic cancer cells have already escaped into the bloodstream or lymphatic system before surgery—referred to as occult spread (hidden spread). These microscopic cells cannot be seen on scans or during surgery, and they can lead to a relapse later even if a perfect R0 resection was achieved [3].

To understand your full prognosis, your doctor will look at your R status alongside your final pathologic stage, which includes:

  • Tumor stage (T): How deeply the tumor invaded the esophageal wall.
  • Lymph node involvement (N): Whether cancer was found in nearby lymph nodes removed during surgery (even if you had an R0 resection, lymph nodes may still contain cancer).
  • Metastasis (M): Whether cancer has spread to distant organs.
  • Treatment response: How much the tumor shrank if you had chemotherapy or radiation before surgery.

Common questions in this guide

What does an R0 resection mean after esophageal cancer surgery?
It means the surgeon saw no visible tumor left during the operation and the pathologist found no cancer cells at the examined edges, or margins, of the removed tissue. R0 describes the surgical site and does not prove that cancer is absent elsewhere in the body.
How is an R1 resection different from an R0 resection?
R1 means no visible tumor was left, but microscopic cancer cells were found at or very near a surgical margin. R0 means no cancer was detected at the examined margins. The definition of a positive or close margin can vary by laboratory, so the measured distance is important.
What does an R2 resection mean in esophageal cancer?
R2 means visible tumor remained after surgery, sometimes because removing it safely would have risked nearby organs or major blood vessels. This result is generally linked with a poorer outlook and may shift treatment goals from surgical cure toward controlling the disease.
Does an R0 resection mean my esophageal cancer is cured?
No. R0 is the best local surgical result, but cancer cells may have spread beyond the surgical site before the operation and may be too small to detect. Doctors also consider the cancer stage, lymph nodes, distant spread, and response to earlier treatment.
Why is the circumferential margin important after esophageal cancer surgery?
The circumferential, or radial, margin is the outer tissue edge around the esophagus. Cancer at or close to this margin can raise the risk of cancer returning in the chest, but laboratories differ in whether they define a positive margin as tumor touching the inked edge or being within 1 millimeter.
What happens if my pathology report shows R1 or R2 status?
An R1 result usually leads to review by a multidisciplinary cancer team. Depending on your health, margin distance, prior chemotherapy or radiation, and other pathology findings, the team may consider additional treatment such as chemotherapy or radiation. R2 status may require a discussion focused on disease control and symptom relief as well as cancer treatment.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Does my pathology report confirm an R0 resection across all margins, and were my proximal, distal, and circumferential margins completely clear?
  2. 2.What definition did the laboratory use for a "positive" margin (e.g., tumor at the ink, or within 1 mm), and exactly how close was my tumor to the edge?
  3. 3.If my results show an R1 resection, will my case be reviewed by a multidisciplinary tumor board to discuss my options?
  4. 4.How does my margin status combine with the number of positive lymph nodes to affect my overall stage and prognosis?
  5. 5.Based on my R status and my response to previous treatments, what is the goal of the next phase of my care?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (7)
  1. 1

    Adjuvant Therapy for Patients with a Tumor-Positive Resection Margin After Neoadjuvant Chemoradiotherapy and Esophagectomy.

    van der Zijden CJ, van der Sluis PC, Mostert B, et al.

    Annals of surgical oncology 2024; (31(6)):3813-3818 doi:10.1245/s10434-024-14912-x.

    PMID: 38245648
  2. 2

    Risk Factors for Tumor Positive Resection Margins After Neoadjuvant Chemoradiotherapy for Esophageal Cancer: Results From the Dutch Upper GI Cancer Audit: A Nationwide Population-Based Study.

    Defize IL, Goense L, Borggreve AS, et al.

    Annals of surgery 2023; (277(2)):e313-e319 doi:10.1097/SLA.0000000000005112.

    PMID: 34334634
  3. 3

    Salvage esophagectomy with pancreatectomy for local recurrence of thoracic esophageal cancer after definitive chemoradiotherapy: A case report.

    Nishiwaki N, Tsubosa Y, Niihara M

    International journal of surgery case reports 2018; (42()):85-89 doi:10.1016/j.ijscr.2017.11.052.

    PMID: 29227857
  4. 4

    The correlation between the margin of resection and prognosis in esophagogastric junction adenocarcinoma.

    Pang T, Nie M, Yin K

    World journal of surgical oncology 2023; (21(1)):316 doi:10.1186/s12957-023-03202-7.

    PMID: 37814242
  5. 5

    Changes in oncological outcomes: comparison of the conventional and minimally invasive esophagectomy, a single institution experience.

    Khan M, Muzaffar A, Syed AA, et al.

    Updates in surgery 2016; (68(4)):343-349 doi:10.1007/s13304-016-0390-z.

    PMID: 27629484
  6. 6

    Positive circumferential resection margin in locally advanced esophageal cancer: an updated systematic review and meta-analysis.

    Wu J, Hu Y, Xu L

    Updates in surgery 2022; (74(4)):1187-1197 doi:10.1007/s13304-022-01256-y.

    PMID: 35212980
  7. 7

    The Role of Adjuvant Therapy in Patients With Margin-Positive (R1) Esophagectomy: A National Analysis.

    Raman V, Jawitz OK, Voigt SL, et al.

    The Journal of surgical research 2020; (249()):82-90 doi:10.1016/j.jss.2019.11.035.

    PMID: 31926400

This page is for informational purposes only and does not constitute medical advice. Your surgeon, pathologist, and oncology team should interpret your pathology report and recommend care for your specific situation.

Get notified when new evidence is published on Carcinoma of esophagus.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.